Real et al., showed that treatment of a metastatic breast cancer cell line with a dominant-negative form of STAT3 sensitized cells to paclitaxel and inhibited STAT3-mediated Bcl-2 induction [40]. This evidence concerns the gene STAT3 and breast cancer.